EP 2651406 A1 20131023 - COMPOSITION CONTAINING RESVERATROL, L-TRYPTOPHAN, L-ASPARTIC ACID AND VITAMIN B3 FOR USE IN THE PHARMACEUTICAL, NUTRITIONAL AND COSMETIC FIELDS
Title (en)
COMPOSITION CONTAINING RESVERATROL, L-TRYPTOPHAN, L-ASPARTIC ACID AND VITAMIN B3 FOR USE IN THE PHARMACEUTICAL, NUTRITIONAL AND COSMETIC FIELDS
Title (de)
ZUSAMMENSETZUNG MIT RESVERATROL, L-TRYPTOPHAN, L-ASPARAGINSÄURE UND VITAMIN B3 ZUR VERWENDUNG IFÜR DIE PHARMAZIE, ERNÄHRUNG UND KOSMETIK
Title (fr)
COMPOSITION À BASE DE RESVÉRATROL, DE L-TRYPTOPHANE, D'ACIDE L-ASPARTIQUE, ET DE VITAMINE B3, CONÇUE POUR DES APPLICATIONS PHARMACEUTIQUES, NUTRITIONNELLES ET COSMÉTIQUES
Publication
Application
Priority
- IT RM20100650 A 20101213
- IB 2011055642 W 20111213
Abstract (en)
[origin: WO2012080952A1] The present invention relates to a composition comprising resveratrol, L-tryptophan, L-aspartic acid and vit. B3 able to control the biosynthesis of nicotinamide adenine dinucleotide (NAD+) for the purpose of producing a greater amount of substrates for reactions catalysed by Sirtuin1 (SIRT1) and increasing the action of resveratrol.
IPC 8 full level
A61K 31/05 (2006.01); A61K 31/198 (2006.01); A61K 31/405 (2006.01); A61K 31/445 (2006.01); A61P 25/00 (2006.01)
CPC (source: EP)
A61K 31/05 (2013.01); A61K 31/198 (2013.01); A61K 31/405 (2013.01); A61K 31/445 (2013.01); A61P 25/00 (2017.12)
Citation (search report)
See references of WO 2012080952A1
Designated contracting state (EPC)
AL AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HR HU IE IS IT LI LT LU LV MC MK MT NL NO PL PT RO RS SE SI SK SM TR
DOCDB simple family (publication)
WO 2012080952 A1 20120621; EP 2651406 A1 20131023; IT 1406221 B1 20140214; IT RM20100650 A1 20120614
DOCDB simple family (application)
IB 2011055642 W 20111213; EP 11813401 A 20111213; IT RM20100650 A 20101213